US2006140925A1PendingUtilityA1
Composition of biochemical compounds involved in bioenergy metabolism of cells and method of use
Est. expiryFeb 14, 2021(expired)· nominal 20-yr term from priority
Inventors:Matthias Rath
A61P 3/08A61P 43/00A61P 3/00A61K 31/198A61K 31/12A23V 2002/00A61K 31/122A61K 38/415A23L 33/10A61K 31/194A61K 31/19
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A composition of biochemical compounds involved in bioenergy metabolism of cells and a method of use in prevention and therapy of diseases are disclosed.
Claims
exact text as granted — not AI-modified1 - 22 . (canceled)
23 . A method for improving bioenergy metabolism of cells comprising administering to a human a composition which comprises a pharmaceutically acceptable carrier; and
Biochemical Substances
Amount
Succinate
0.01-100
mg;
Fumarate
0.01-100
mg;
L-Malate
0.01-100
mg; and
α-Ketoglutarate
0.01-100
mg.
24 . A method for improving bioenergy metabolism of cells comprising administering to a human a composition which comprises a pharmaceutically acceptable carrier; and
Biochemical Substances
Amount
Pyruvate
0.01-100
mg;
Acetyl -Coenzyme a
0.01-100
mg;
Citrate
0.01-200
mg;
Cis-Aconitate
0.01-100
mg;
Isocitrate
0.01-100
mg;
Oxalosuccinate
0.01-100
mg;
2-Oxo-Glutarate
0.01-100
mg;
Succinyl-
0.01-100
mg;
Coenzyme A and
Oxaloacetate
0.01-100
mg.
25 . A method for improving bioenergy metabolism of cells comprising administering to a human a composition which comprises a pharmaceutically acceptable carrier; and
Biochemical Substances
Amount
Lipoic Acid
0.01-100
mg;
Lipoamide (Lipoic Acid + Lysine);
0.01-100
mg
Acetyl-Lipoamide
0.01-100
mg;
Lysine
0.01-100
mg;
Carnitine
0.01-100
mg;
Ascorbate
0.01-200
mg;
Thiamine
0.01-10
mg;
Riboflavin
0.01-10
mg;
Nicotinic Acid
0.01-10
mg;
Niacinamide
0.01-10
mg;
Pantothenate
0.01-10
mg;
Nicotinamide-Adenine
0.01-10
mg;
Dinucleotide (NAD)
Reduced Nicotinamide
0.01-10
mg;
Adenine
Dinucleotide
Nicotinamide-Adenine
0.01-10
mg;
Dinucleotide
Phosphate (NADP)
reduced NADP (NADPH)
0.01-10
mg;
Quinolinate
0.01-10
mg;
(NAD/NADP precursor)
Flavin-Adenine
0.01-10
mg;
Dinucleotide (FAD)
Reduced Flavin-Adenine
0.01-10
mg;
Dinucleotide (FADH)
Flavin Mononucleotide
0.01-10
mg;
(FMN)
Reduced Flavin
0.01-10
mg;
Mononucleotide (FMNH 2 )
Adenosine, Diphosphate
0.01-10
mg;
(ADP)
Adenosine, Triphosphate
0.01-10
mg;
(ATP)
Guanosine Diphosphate
0.01-10
mg;
(GDP)
Guanosine Triphosphate
0.01-10
mg;
(GTP)
Magnesium (Mg 2+ )
0.01-10
mg;
Calcium (Ca 2+ )
0.01-10
mg;
Manganese (Mn 2+ )
0.01-10
mg;
Copper
0.01-10
mg;
Iron-Sulfate
0.01-10
mg; and
Molybdenum
0.01-10
mg.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.